San Diego, CA — CellarisBio today announced the issuance of its flagship U.S. patent covering the MICRO-TAG® technology platform and the commercial launch of its first MICRO-TAG® reagent product line at the SLAS 2026 International Conference & Exhibition in Boston. These milestones position MICRO-TAG® as a real-time cellular target engagement platform for drug discovery across both […]

A new in-plate, zero-disruption design enables reproducible organoid culture, downstream processing, and high-resolution imaging in a single 3D cell culture plate Monmouth Junction, NJ — TheWell Bioscience today announced the launch of the VitroPrime™ 3D Culture and Imaging Plate, a next-generation 3D cell culture plate engineered to support organoid and advanced 3D cell culture workflows with minimal […]

TarSeer™ BRETSA™ Target Engagement System enables studies for difficult proteins early in drug discovery MADISON, Wis. — Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate proteins. The TarSeer™ BRETSA™ Target Engagement System is a novel bioluminescence resonance energy transfer-based […]

Integrated Platform Enables up to 3X Higher Throughput for Antibody Discovery and Characterization; Joint Solution Addresses Growing Demand from AI Drug Design Companies, Pharma, and CROs PALO ALTO, CA and SPRINGFIELD, NJ – Gator Bio, a leader in biolayer interferometry (BLI) systems, and Hudson Lab Automation, Inc., a leading laboratory automation provider, today announced the availability […]

Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors Forms a global life sciences and diagnostics leader focused on high-volume testing in regulated applications Announces formation of four divisions: Waters Analytical Sciences, Waters Biosciences, Waters Advanced Diagnostics, and Waters Materials Sciences MILFORD, Mass. — Waters Corporation (NYSE: WAT) (“Waters”) today announced it has completed […]

A new in-plate, zero-disruption design enables reproducible organoid culture, downstream processing, and high-resolution imaging in a single 3D cell culture plate MONMOUTH JUNCTION, N.J. — TheWell Bioscience today announced the launch of the VitroPrime™ 3D Culture and Imaging Plate, a next-generation 3D cell culture plate engineered to support organoid and advanced 3D cell culture workflows with minimal […]

New launches in high-content imaging, detection, and automation help labs accelerate drug discovery workflows from sample to insight WALTHAM, Mass. — Revvity, Inc. (NYSE: RVTY) announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate high-throughput drug discovery workflows. Making their debut at the conference in Boston, February 7-11, […]

New ready-to-use kit combines Pluristyx’s high-quality pluripotent cells and mRNA technology with Solesis’ proprietary transfection technology to achieve nearly 100% transfection efficiency and exogenous gene expression in dynamic suspension (3D) cultures. SEATTLE, WA & TELFORD, PA – Pluristyx, Inc., a leading provider of induced pluripotent stem cell (iPSC)-based technologies, and Solesis, a leader in biomaterials and […]

New ready-to-use kit combines Pluristyx’s high-quality pluripotent cells and mRNA technology with Solesis’ proprietary transfection technology to achieve nearly 100% transfection efficiency and exogenous gene expression in dynamic suspension (3D) cultures. SEATTLE, WA & TELFORD, PA – Pluristyx, Inc., a leading provider of induced pluripotent stem cell (iPSC)-based technologies, and Solesis, a leader in biomaterials and […]

SUNNYVALE, Calif. — Integrated DNA Technologies (IDT), a global leader in genomics, today issued the following statement about the recent landmark federal legislation that marks a significant step towards Medicare coverage for FDA-approved multi-early cancer detection (MCED) tests. IDT President Ajay Gannerkote says, “IDT has been a driving force in supporting the development of multi‑cancer […]